• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Palatin Technologies (NY: PTN )

    0.8831 +0.0551 (+6.65%)
    Official Closing Price Updated: 8:00 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 229,076
    Open 0.8900
    Bid (Size) 0.8600 (51)
    Ask (Size) 0.9260 (3)
    Prev. Close 0.8280
    Today's Range 0.8200 - 0.9099
    52wk Range 0.6800 - 5.650
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions
    Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions 
    Via News Direct
    Exposures Product Safety

    Performance

    YTD
    -77.12%
    -77.12%
    1 Month
    -39.72%
    -39.72%
    3 Month
    -50.94%
    -50.94%
    6 Month
    -49.82%
    -49.82%
    1 Year
    -51.21%
    -51.21%

    More News

    Read More
    PTN Stock Earnings: Palatin Techs Misses EPS for Q3 2024
    Via InvestorPlace
    Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For February 15, 2024
    Via Benzinga
    Earnings Preview: Palatin Techs
    Via Benzinga
    Recap: Palatin Techs Q1 Earnings
    Via Benzinga
    Palatin Techs's Earnings Outlook
    Via Benzinga
    Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
    Via Benzinga
    Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Palatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock Plummets
    Via Benzinga
    Dow Dips 200 Points; TJX Posts Upbeat Sales
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    The 3 Best Penny Stocks to Buy in February 2024
    Via InvestorPlace
    7 Analyst-Backed Stocks With Promising 10-Bagger Potential
    Via InvestorPlace
    3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
    Via InvestorPlace
    Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
    From Cosette Pharmaceuticals, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Analysts Say 3 Stocks Have a Combined Upside of 3000%
    Via InvestorPlace
    Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
    Via FinancialNewsMedia
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.